A signaling visualization toolkit to support rational design of combination therapies and biomarker discovery: SiViT

Targeted cancer therapy aims to disrupt aberrant cellular signalling pathways. Biomarkers are surrogates of pathway state, but there is limited success in translating candidate biomarkers to clinical practice due to the intrinsic complexity of pathway networks. Systems biology approaches afford better understanding of complex, dynamical interactions in signalling pathways targeted by anticancer drugs. However, adoption of dynamical modelling by clinicians and biologists is impeded by model inaccessibility. Drawing on computer games technology, we present a novel visualisation toolkit, SiViT, that converts systems biology models of cancer cell signalling into interactive simulations that can be used without specialist computational expertise. SiViT allows clinicians and biologists to directly introduce for example loss of function mutations and specific inhibitors. SiViT animates the effects of these introductions on pathway dynamics, suggesting further experiments and assessing candidate biomarker effectiveness. In a systems biology model of Her2 signalling we experimentally validated predictions using SiViT, revealing the dynamics of biomarkers of drug resistance and highlighting the role of pathway crosstalk. No model is ever complete: the iteration of real data and simulation facilitates continued evolution of more accurate, useful models. SiViT will make accessible libraries of models to support preclinical research, combinatorial strategy design and biomarker discovery.

Modélisation et analyse d'une machine à absorption/compression hybride fonctionnant à partir de rejets thermiques basse température

Les applications de réfrigération sont aujourd’hui majoritairement réalisées par des machines à compression alimentées en électricité. Animées à partir d’une source chaude, l’utilisation de machines à absorption permet d’utiliser très peu d’électricité comparée à une machine à compression et d’utiliser des réfrigérants écologiques. Le faible coefficient de performance et le coût élevé de ces machines est compensé par l’utilisation de rejets thermiques industriels destinés à être rejeté dans l’environnement et donc considérés comme gratuits. Le but de cette étude est de modéliser une machine à absorption hybride, utilisant le couple de fluide eau et ammoniac, en y ajoutant un compresseur ou booster dans la zone haute pression du circuit et d’évaluer ses performances. Cette modification crée une pression intermédiaire au désorbeur permettant de diminuer la température des rejets thermiques exploitables. Une température de rejets réutilisable de 50°C, contre 80°C actuellement, ouvrirait alors la voie à de nouvelles sources communes d’énergie. Le logiciel ASPEN Plus de simulation des procédés a été choisi afin de modéliser en régime permanent le système. Le modèle est en partie validé par l’étude expérimentale d’une machine à absorption commerciale de 10kW pour des applications de climatisation. Cette machine est située au Laboratoire des Technologies de l’Énergie d’Hydro-Québec. Ensuite, une étude de design permet de montrer, à puissance de réfrigération constante, les impacts bénéfiques de la technologie hybride sur le rendement exergétique, mais également sur la taille globale des échangeurs nécessaires. La technologie hybride est alors analysée économiquement face à une machine à absorption chauffée au gaz pour montrer sa rentabilité.

Étude du comportement des fluides magnétorhéologiques (MR) en compression-cisaillement simultanée

Les fluides magnétorhéologiques (MR) sont des fluides intelligents dont la viscosité apparente peut être modifiée rapidement (<1ms) par l'application d'un champ magnétique externe. À l'aide de cette caractéristique unique, les embrayages MR permettent de moduler rapidement un couple entre deux surfaces sans contact mécanique direct. De construction simple et robuste, les embrayages MR offrent ainsi un potentiel remarquable d'innovation pour diverses applications robotiques nécessitant un contrôle rapide et une haute fiabilité, comme dans les domaines de l'automobile [10], de l'aéronautique [16] ou de l'interaction humaine [77]. À ce jour, les embrayages MR exploitent le fluide MR strictement en cisaillement pur. Dans de telles conditions, la densité de couple des embrayages est limitée par l'optimisation de la mécanique des embrayages (ex. : poids) [63] et les propriétés fondamentales des fluides MR (ex. : contrainte) [11]. Alors qu'en cisaillement pur, la contrainte des fluides MR est limitée à ∼100 kPa, des études récentes démontrent qu'elle peut être augmentée d'un ordre de grandeur (>1000 kPa) lorsque le fluide MR est soumis à une compression, avant d'être cisaillé [89]. La combinaison de la compression et du cisaillement du fluide MR pourrait ainsi décupler la densité de couple des embrayages MR, mais ce phénomène d'agrégation assistée par compression, aussi appelé squeeze-strengthening ou super-strong} (SS), est toujours très mal compris. Beaucoup d'incertitude persiste quant à l'origine exacte du phénomène [45], des conditions qui le favorisent [55] [75] et des effets qu'il engendre [31]. Dans le but ultime d'augmenter la densité de couple des embrayages MR à l'aide du phénomène SS, le présent projet de recherche vise à étudier le comportement rhéologique des fluides MR dans des conditions de compression et de cisaillement simultané afin d'en comprendre les conditions qui favorisent le phénomène d'augmentation des contraintes. Pour ce faire, un banc d'essai permettant la compression pure, le cisaillement pur et la compression-cisaillement simultanée des fluides MR est conçu et utilisé pour étudier le fluide MR lorsque soumis à des conditions de chargement typique des embrayages MR. Les résultats expérimentaux issus de cette vaste étude expérimentale permettront d'établir un lien direct entre ce phénomène et le celui de filtration, duquel un modèle prédictif sera proposé. À l'aide du modèle théorique, le phénomène SS sera étudié à l'aide de diverses compositions de fluide MR (ex. : concentration, taille des particules, viscosité) et différentes géométries de compression, ce qui permettra de valoriser le modèle pour la conception préliminaire d'embrayages MR qui exploitent le phénomène SS.

BATTERY POWERED PORTABLE VAPOR COMPRESSION CYCLE SYSTEM WITH PCM CONDENSER

A battery powered air-conditioning device was developed to provide an improved thermal comfort level for individuals in inadequately cooled environments. This device is a battery powered air-conditioning system with the phase change material (PCM) for heat storage. The condenser heat is stored in the PCM during the cooling operation and is discharged while the battery is charged by using the vapor compression cycle as a thermosiphon loop. The main focus of the current research was on the development of the cooling system. The cooling capacity of the vapor compression cycle measured was 165.6 W with system COP at 2.85. It was able to provide 2 hours cooling without discharging heat to the ambient. The PCM was recharged in nearly 8 hours under thermosiphon mode.

Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies

International audience

Compression stockings and the prevention of symptomatic venous thromboembolism: data from the Tinzaparin in Acute Ischaemic Stroke Trial

Background: Venous thromboembolism (VTE) is a well recognised and preventable complication of acute stroke. While graduated compression stockings reduce the risk of VTE in surgical patients their benefit in acute stroke remains uncertain. Methods: The relationship between symptomatic VTE and use of stockings using observational data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’, which compared 10 days of treatment with tinzaparin (175 IU.kg-1 or 100 IU.kg-1) with, aspirin (300 mg od), was assessed using logistic regression adjusted for known VTE risk factors and treatment. Results: Symptomatic VTE occurred in 28 patients (1.9%, DVT 18, PE 13) within 15 days of enrolment in 1,479 patients. Patients wearing one or two stockings for any period of time during the first 10 days (n=803) had a non-significant increase (odds ratio, OR 2.45, 95% confidence interval, CI 0.95 - 6.32) in the risk of symptomatic VTE. In contrast, those wearing bilateral stockings for 10 days (n=374) had a non-significant reduction in the odds of symptomatic VTE as compared to those who wore no stockings or wore them for less than 10 days (OR 0.65, 95% CI 0.26-1.65). Mild stroke and treatment with tinzaparin were associated with a reduced risk of VTE. Conclusions: Bilateral graduated compression stockings may reduce the incidence of VTE by one-third in patients with acute ischaemic stroke. However, the uncertainty in this finding, low frequency of symptomatic VTE, potential for stockings to cause harm, and cost of stockings highlight the need for a large randomised-controlled trial to examine the safety and efficacy of stockings in acute stroke.

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

Background: Non-small cell lung cancer (NSCLC) imposes a substantial burden on patients, health care systems and society due to increasing incidence and poor survival rates. In recent years, advances in the treatment of metastatic NSCLC have resulted from the introduction of targeted therapies. However, the application of these new agents increases treatment costs considerably. The objective of this article is to review the economic evidence of targeted therapies in metastatic NSCLC. Methods: A systematic literature review was conducted to identify cost-effectiveness (CE) as well as cost-utility studies. Medline, Embase, SciSearch, Cochrane, and 9 other databases were searched from 2000 through April 2013 (including update) for full-text publications. The quality of the studies was assessed via the validated Quality of Health Economic Studies (QHES) instrument. Results: Nineteen studies (including update) involving the MoAb bevacizumab and the Tyrosine-kinase inhibitors erlotinib and gefitinib met all inclusion criteria. The majority of studies analyzed the CE of first-line maintenance and second-line treatment with erlotinib. Five studies dealt with bevacizumab in first-line regimes. Gefitinib and pharmacogenomic profiling were each covered by only two studies. Furthermore, the available evidence was of only fair quality. Conclusion: First-line maintenance treatment with erlotinib compared to Best Supportive Care (BSC) can be considered cost-effective. In comparison to docetaxel, erlotinib is likely to be cost-effective in subsequent treatment regimens as well. The insights for bevacizumab are miscellaneous. There are findings that gefitinib is cost-effective in first- and second-line treatment, however, based on only two studies. The role of pharmacogenomic testing needs to be evaluated. Therefore, future research should improve the available evidence and consider pharmacogenomic profiling as specified by the European Medicines Agency. Upcoming agents like crizotinib and afatinib need to be analyzed as well. © Lange et al.

Spatiotemporal neuromodulation therapies engaging muscle synergies improve motor control after spinal cord injury.

Electrical neuromodulation of lumbar segments improves motor control after spinal cord injury in animal models and humans. However, the physiological principles underlying the effect of this intervention remain poorly understood, which has limited the therapeutic approach to continuous stimulation applied to restricted spinal cord locations. Here we developed stimulation protocols that reproduce the natural dynamics of motoneuron activation during locomotion. For this, we computed the spatiotemporal activation pattern of muscle synergies during locomotion in healthy rats. Computer simulations identified optimal electrode locations to target each synergy through the recruitment of proprioceptive feedback circuits. This framework steered the design of spatially selective spinal implants and real-time control software that modulate extensor and flexor synergies with precise temporal resolution. Spatiotemporal neuromodulation therapies improved gait quality, weight-bearing capacity, endurance and skilled locomotion in several rodent models of spinal cord injury. These new concepts are directly translatable to strategies to improve motor control in humans.

3D Porous Architecture of Stacks of β-TCP Granules Compared with That of Trabecular Bone: A microCT, Vector Analysis, and Compression Study

International audience